Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 465, Issue 1-2, Pages 39-41Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-2999(03)01485-7
Keywords
FP prostanoid receptor; cyclooxygenase-2; beta-catenin signaling
Categories
Funding
- NEI NIH HHS [EY11291] Funding Source: Medline
Ask authors/readers for more resources
We have recently shown that the FPB prostanoid receptor activates beta-catenin signaling through the activation of Rho in human embryo kidney (HEK)-293 cells stably expressing the FPB receptors. We now report that the FPB receptor can stimulate cyclooxygenase-2 promoter activity and may, therefore, regulate the expression of cyclooxygenase-2. This stimulation of cyclooxygenase-2 promoter activity is blocked by pretreatment with an inhibitor of Rho, but not with an inhibitor of protein kinase C (PKC). Potential up regulation of cyclooxygenase-2 expression by the FPB receptor would establish a positive feedback loop that would drive beta-catenin signaling and could be involved in cancer. (C) 2003 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available